510 related articles for article (PubMed ID: 29486758)
1. A stakeholder co-design approach for developing a community pharmacy service to enhance screening and management of atrial fibrillation.
Sabater-Hernández D; Tudball J; Ferguson C; Franco-Trigo L; Hossain LN; Benrimoj SI
BMC Health Serv Res; 2018 Feb; 18(1):145. PubMed ID: 29486758
[TBL] [Abstract][Full Text] [Related]
2. Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease.
Franco-Trigo L; Hossain LN; Durks D; Fam D; Inglis SC; Benrimoj SI; Sabater-Hernández D
Res Social Adm Pharm; 2017; 13(3):539-552. PubMed ID: 27485770
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation.
Lowres N; Krass I; Neubeck L; Redfern J; McLachlan AJ; Bennett AA; Freedman SB
Int J Clin Pharm; 2015 Dec; 37(6):1111-20. PubMed ID: 26202627
[TBL] [Abstract][Full Text] [Related]
4. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
5. A stakeholder visioning exercise to enhance chronic care and the integration of community pharmacy services.
Franco-Trigo L; Tudball J; Fam D; Benrimoj SI; Sabater-Hernández D
Res Social Adm Pharm; 2019 Jan; 15(1):31-44. PubMed ID: 29496521
[TBL] [Abstract][Full Text] [Related]
6. Collaborative health service planning: A stakeholder analysis with social network analysis to develop a community pharmacy service.
Franco-Trigo L; Marqués-Sánchez P; Tudball J; Benrimoj SI; Martínez-Martínez F; Sabater-Hernández D
Res Social Adm Pharm; 2020 Feb; 16(2):216-229. PubMed ID: 31133537
[TBL] [Abstract][Full Text] [Related]
7. Co-design and feasibility of a pharmacist-led minor ailment service.
Dineen-Griffin S; Benrimoj SI; Williams KA; Garcia-Cardenas V
BMC Health Serv Res; 2021 Jan; 21(1):80. PubMed ID: 33482801
[TBL] [Abstract][Full Text] [Related]
8. Development of a clinical pharmacy model within an Australian home nursing service using co-creation and participatory action research: the
Elliott RA; Lee CY; Beanland C; Goeman DP; Petrie N; Petrie B; Vise F; Gray J
BMJ Open; 2017 Nov; 7(11):e018722. PubMed ID: 29102998
[TBL] [Abstract][Full Text] [Related]
9. A multilevel stakeholder approach for identifying the determinants of implementation of government-funded community pharmacy services at the primary care level.
Hossain LN; Tudball J; Franco-Trigo L; Durks D; Benrimoj SI; Sabater-Hernández D
Res Social Adm Pharm; 2018 Aug; 14(8):765-775. PubMed ID: 29033347
[TBL] [Abstract][Full Text] [Related]
10. Pharmacists in general practice: a qualitative interview case study of stakeholders' experiences in a West London GP federation.
Ryan K; Patel N; Lau WM; Abu-Elmagd H; Stretch G; Pinney H
BMC Health Serv Res; 2018 Apr; 18(1):234. PubMed ID: 29609603
[TBL] [Abstract][Full Text] [Related]
11. A developmental evaluation of an intraprofessional Pharmacy Communication Partnership (PROMPT) to improve transitions in care from hospital to community: A mixed-methods study.
Guilcher SJT; Fernandes O; Luke MJ; Wong G; Lui P; Cameron K; Pariser P; Raco V; Kak K; Varghese S; Papastergiou J; McCarthy LM
BMC Health Serv Res; 2020 Feb; 20(1):99. PubMed ID: 32041591
[TBL] [Abstract][Full Text] [Related]
12. A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation.
Fathima M; Saini B; Foster JM; Armour CL
Res Social Adm Pharm; 2019 Jun; 15(6):662-672. PubMed ID: 30131254
[TBL] [Abstract][Full Text] [Related]
13. Community pharmacy integration within the primary care pathway for people with long-term conditions: a focus group study of patients', pharmacists' and GPs' experiences and expectations.
Hindi AMK; Schafheutle EI; Jacobs S
BMC Fam Pract; 2019 Feb; 20(1):26. PubMed ID: 30736732
[TBL] [Abstract][Full Text] [Related]
14. Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners.
Hossain LN; Fernandez-Llimos F; Luckett T; Moullin JC; Durks D; Franco-Trigo L; Benrimoj SI; Sabater-Hernández D
BMJ Open; 2017 Sep; 7(9):e015471. PubMed ID: 28877940
[TBL] [Abstract][Full Text] [Related]
15. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies.
Murphy AL; Martin-Misener R; Kutcher SP; O'Reilly CL; Chen TF; Gardner DM
BMC Health Serv Res; 2016 Oct; 16(1):569. PubMed ID: 27729051
[TBL] [Abstract][Full Text] [Related]
16. Pharmacists detecting atrial fibrillation in general practice: a qualitative focus group study.
Savickas V; Veale EL; Bhamra SK; Stewart AJ; Mathie A; Corlett S
BJGP Open; 2020 Aug; 4(3):. PubMed ID: 32576574
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation management services in community pharmacy: Feasibility of implementing a quality improvement programme through a practice-based research network.
Chartrand M; Lalonde L; Cantin A; Lahaie A; Odobasic B; Tremblay MP; Wazzan D; Gagnon MM; Martin É; Dorais M; Berbiche D; Guénette L
J Clin Pharm Ther; 2018 Dec; 43(6):877-887. PubMed ID: 30019341
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing national implementation of innovations within community pharmacy: a systematic review applying the Consolidated Framework for Implementation Research.
Weir NM; Newham R; Dunlop E; Bennie M
Implement Sci; 2019 Mar; 14(1):21. PubMed ID: 30832698
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
20. A qualitative study of stakeholder views and experiences of minor ailment services in the United Kingdom.
Aly M; García-Cárdenas V; Williams KA; Benrimoj SI
Res Social Adm Pharm; 2019 May; 15(5):496-504. PubMed ID: 29941403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
